Latest from Clinigen
Careers / vacancies
We’re looking for people who want to make a difference
Clinigen Direct
The personal assistant every pharmacist wishes they had.
Investor Relations
Press releases
- Half Year Results for the Six Months Ended 31 December 2020 23 Feb 2021
- Clinigen partners with Karyopharm to distribute XPOVIO® (selinexor) to patients outside of the United States as part of a Named Patient Program 15 Feb 2021
- Restatement of segmental reporting 11 Feb 2021
Investment case
WHAT IS OUR INVESTMENT CASE?
In becoming the trusted global leader in access to medicines, the Group has consistently delivered healthy financial performances and returns. Read more about our Investment Case by clicking on the link below.
View our Investment CaseVideo: Clinigen Group
The Clinigen Solution to Clinical Trial Closure
This is what a Managed Access Program looks like with Clinigen - ethical, compliant and patient focused.
Play videoClinigen’s mission is to deliver the right medicine to the right patient at the right time, to improve the quality of people’s lives around the world. There are only three ways for a patient to ethically access a medicine: through a clinical trial, unlicensed or commercial route and we are the only company to globally manage access across all three routes.
Our missionemployees across five continents in 14 countries
units shipped in the last year
pharmacist relationships across over 100 countries
local knowledge in 130 countries across the world